Skip to main content

A PHASE Ib, MULTICENTER, OPEN-LABELSTUDY TO EVALUATE THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF CIBISATAMAB IN COMBINATION WITH ATEZOLIZUMAB AFTER PRETREATMENT WITH OBINUTUZUMAB IN PATIENTS WITH PREVIOUSLY TREATED METASTATIC, MICROSATELLITE-STABL

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

July 24, 2019

End Date

December 8, 2023
 

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

July 24, 2019

End Date

December 8, 2023